Bambusa Therapeutics
Clinical trials sponsored by Bambusa Therapeutics, explained in plain language.
-
First human tests begin for experimental COPD treatment
Disease control Recruiting nowThis early-stage study is testing the safety of a new drug called BBT002 in people with chronic obstructive pulmonary disease (COPD). Researchers will give increasing doses to healthy volunteers and then to people with COPD to see how their bodies handle the drug and check for si…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New eczema drug enters first human safety tests
Disease control Recruiting nowThis is an early-stage study to check the safety and basic effects of a new drug called BBT001. It will first test single doses in healthy volunteers, then test repeated doses in adults with moderate to severe atopic dermatitis (eczema). The main goal is to see how well people to…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First human tests begin for new eczema injection
Disease control Recruiting nowThis is an early-stage study to check the safety of a new drug called BBT001 for people with moderate-to-severe eczema (atopic dermatitis). Researchers will give the drug to healthy volunteers and eczema patients in increasing doses to see how well it is tolerated and how it move…
Phase: PHASE1 • Sponsor: Bambusa Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC